Sponsor:
Wake Forest University Health Sciences
Code:
NCT06897137
Conditions
Malignant Solid Neoplasm
Hematopoietic Neoplasms
Lymphatic System Neoplasm
Eligibility Criteria
Sex: All
Age: 15+
Healthy Volunteers: Accepted
Interventions
Surveys/Questionnaires
Brief summary:
Conditions
Malignant Solid Neoplasm
Hematopoietic Neoplasms
Lymphatic System Neoplasm
Study ID
NCT06897137
Start date
Apr 26, 2026
Status verified date
Jun, 2026
Completion date
Jan, 2028
Anticipated
Primary completion date
Jan, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 15+
Healthy Volunteers: Accepted
Enrollment
3000 participants
Anticipated
Arms
Observational
Interventions
Surveys/Questionnaires
Primary outcome measure
Central contacts
Locations
Wake Forest Baptist Comprehensive Cancer Center
Recruiting
Winston-Salem, North Carolina, United States, 27157
Contacts
Principal Investigator:
John M Salsman, PhD
Sponsor
Wake Forest University Health Sciences
Last update posted
Jun 30, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2026-06-30.